🦾 Meet the robotic exoskeletons restoring mobility

In partnership with

The Game is Changing

The internet was supposed to make it easier to build and connect. Somewhere along the way, we lost the plot.

beehiiv is changing that once and for all.

On November 13, they’re unveiling what’s next at their first-ever Winter Release Event. For the people shaping the future of content, community, and media, this is an event you can’t miss.

RSVP today

Welcome back to Healthy Innovations! 👋

Last week, millions of people watched 24-year-old Jessica Tawil walk for the first time in over a decade - with the help of a mobility exoskeleton. Tawil, an influencer paralyzed in a 2014 car accident, captured hearts worldwide with this milestone moment.

For millions living with spinal cord injuries, stroke effects, and progressive neurological conditions, this technology could transform lives.

So this week, let's dive deep into the fascinating world of robotic exoskeletons!

A spinal cord injury leaves you paralyzed from the waist down. Doctors tell you that you'll spend the rest of your life in a wheelchair. Six months later, you're standing upright, taking steps, and hugging your family heart-to-heart instead of from a seated position.

This isn't a miracle - it's exoskeleton technology, and it's rapidly moving from rehabilitation centers into patients' homes and communities.

The global exoskeleton market is projected to grow from approximately $498 million in 2024 to $1.25 billion by 2030, reflecting increasing confidence that these remarkable devices represent far more than experimental therapy. They're becoming a legitimate pathway to restored mobility for people with spinal cord injuries, stroke survivors, and individuals living with conditions like multiple sclerosis and cerebral palsy.

From rehabilitation to real life: Understanding exoskeletons

A robotic exoskeleton is a wearable device that combines mechanical structures, sensors, and actuators to work in tandem with the human body, assisting or enhancing physical movement. Unlike prosthetics that replace missing limbs, exoskeletons support and augment existing body parts that have lost function.

These sophisticated devices range from rigid, powered systems that provide substantial joint support for patients with severe impairments, to lightweight soft "exosuits" made from flexible materials that assist those with milder deficits. Modern exoskeletons integrate multiple technologies: microprocessors that coordinate movements, sensors that detect user intent, actuators that provide powered assistance, and increasingly, artificial intelligence that learns and adapts to individual walking patterns.

For rehabilitation purposes, these devices enable repetitive, task-specific gait training that promotes motor learning, reduces therapist burden, and facilitates improvement in walking parameters including speed, endurance, and gait symmetry.

The Olympic moment that changed everything

Perhaps no single event has done more to raise awareness of exoskeleton technology than what happened at the 2024 Paris Olympics.

Kevin Piette, a Paralympian who typically uses a wheelchair, became the first user of a self-balancing exoskeleton to walk in the Olympic torch relay. Wearing Wandercraft's Eve Personal Exoskeleton, Piette carried the flame through a village outside Paris - standing upright, walking independently, without crutches or walkers.

The moment symbolized both how far exoskeleton technology has come and where it's heading.

The comprehensive health benefits

The benefits extend well beyond mobility itself.

Studies show that regular exoskeleton-assisted walking programs result in improved spasticity, trunk control, bowel and bladder function, and mental health for people with spinal cord injuries.

When paralyzed individuals can bear weight and move in an upright position, their bodies respond. Cardiovascular health improves. Bone density is maintained. Pressure ulcers - a serious complication of prolonged wheelchair use - are prevented. The psychological benefits are equally significant: standing at eye level changes social interactions, reduces depression, and restores a sense of autonomy.

The breakthrough: Self-balancing technology

The game-changer? Self-balancing exoskeletons that eliminate the need for crutches or walkers - leaving users' hands completely free.

Wandercraft's Eve Personal Exoskeleton represents this new frontier. The device integrates AI to continuously adapt to a user's movements in real-time, supporting smooth and stable walking across different surfaces. The system requires just five training sessions and is trained on billions of simulations and tens of millions of real-world steps.

Clinical trials for Eve are currently underway at the James J. Peters VA Medical Center in the Bronx and the Kessler Institute for Rehabilitation in New Jersey. Wandercraft aims to apply for FDA clearance immediately following trial completion, with commercial launch expected in 2026 and anticipated Medicare coverage. The company opened its first U.S. clinic, "Walk in New York," in Manhattan, offering personalized neurorehabilitation.

Leading medical exoskeleton companies

Wandercraft's Atalante X is FDA-cleared and deployed in over 100 rehabilitation centers across four continents, with patients taking over one million steps per month. The technology featured prominently at CES 2025 when NVIDIA CEO Jensen Huang showcased it during his keynote.

Ekso Bionics operates in more than 500 rehabilitation centers worldwide. The Ekso Indego Personal is the lightest weight exoskeleton available, enabling individuals paralyzed from SCI (level T3-L5) to stand and walk at home.

Lifeward (formerly ReWalk Robotics) offers the only personal exoskeleton that enables access to environments with stairs and curbs - critical for real-world mobility. Significantly, the ReWalk Personal Exoskeleton was assigned to the Medicare brace benefit category as of January 1, 2024, making it covered by Medicare where reasonable and necessary - a game-changing development for accessibility.

Cyberdyne's HAL (Hybrid Assistive Limb) uses brain signals to help people recovering from spinal cord injuries or paralysis to stand and walk, representing an important integration of neurotechnology with robotic assistance.

Barriers to widespread adoption

Despite promising results, significant challenges remain:

• Cost remains the primary barrier. Advanced systems range from $40,000 to over $100,000.

• Patient eligibility is limited. Users need adequate trunk control, bone density to withstand weight-bearing, and the ability to tolerate standing. Older individuals with spinal cord injuries may face additional challenges meeting these requirements.

• Training demands are substantial. Both users and supervising therapists require extensive instruction, limiting accessibility to specialized centers.

• Evidence gaps persist. While early results are encouraging, researchers emphasize that limited sample sizes in current studies mean it's premature to draw definitive conclusions about long-term efficacy. Larger, multicenter trials are needed.

The path forward: 3, 5, and 10 years

Within 3 years: Commercial availability of self-balancing exoskeletons like Eve, expanded Medicare coverage, and integration of AI that adapts to individual patient needs in real-time. Expect exoskeletons prescribed for stroke recovery, multiple sclerosis, and Parkinson's disease beyond current spinal cord injury applications.

Within 5 years: Dramatically lighter devices comfortable for extended daily wear, home-delivery fitting programs, and combination therapies merging functional electrical stimulation with mechanical support. Brain-computer interfaces will enable more intuitive control for patients with limited upper body mobility.

Within 10 years: Mainstream adoption in rehabilitation medicine, with exoskeletons as common as wheelchairs for eligible patients. Neural implants may directly interface with control systems. Rental and subscription models will improve affordability. Self-balancing technology will be standard, eliminating crutch requirements entirely.

Why this transformation matters

The transformation we're witnessing in mobility assistance isn't just about technology - it's about restoring what paralysis takes away: independence, health, and human connection. When someone can stand to hug their child, walk alongside friends, or simply look others in the eye during conversation, we're reminded that innovation's greatest power lies in its ability to restore dignity.

As self-balancing exoskeletons move from research labs to living rooms, and as Medicare coverage makes them accessible to more patients, we're approaching a future where paralysis no longer means permanent immobility. The millions of people who watched Jessica Tawil take those first steps weren't just witnessing a personal triumph - they were glimpsing the future of rehabilitation medicine.

For the millions living with spinal cord injuries, stroke effects, and progressive neurological conditions, that future can't come soon enough. But with companies like Wandercraft, Lifeward, and Ekso Bionics pushing boundaries, and with AI making these devices smarter and more intuitive, we're not just imagining that future - we're walking toward it.

Innovation highlights

🎤 Hydrogel hits high notes. Researchers developed a long-lasting hydrogel that could help people recover from vocal cord injuries. Using click chemistry as "molecular glue," the gel stays intact for weeks - much longer than current treatments that break down quickly. Voice disorders affect 1 in 13 adults each year, especially singers, teachers, and those with reflux. After successful lab tests, the team plans computer simulations before moving to human trials.

💡 Lights, camera, cancer action. Scientists have developed a light-based cancer therapy using LED lights and tin nanoflakes that killed 92% of skin cancer cells in 30 minutes - without harming healthy tissue. Unlike expensive laser treatments or harsh chemotherapy, this approach could become portable and affordable. Researchers envision at-home devices for treating skin cancers, eliminating hospital visits and reducing side effects for patients worldwide.

🧬 Googling your genetic code. Scientists have created MetaGraph - a "Google for DNA" that searches 100 petabytes of global genetic databases in seconds. Previously, researchers had to download entire datasets, a time-consuming and expensive process. The tool compresses data by 300x and could accelerate research on pathogens, antibiotic resistance, and pandemics. Half the world's sequence data is already indexed, with more on the way.

Company to watch

🏥 Healthily is tackling health insurance's billion-dollar navigation problem with Dot™, their AI-powered virtual health assistant.

This London-based company's medically verified platform (Class IIa Medical Device) addresses costly inefficiencies: 30% of appointments are for self-treatable conditions, 20% involve wrong specialist bookings, and 25% of digital visits are unnecessary. Dot™ uses sophisticated AI to assess conditions, guide members to appropriate care or self-care solutions, and could resolve up to 85% of call center inquiries without human intervention.

With €25 million backing from Reckitt Benckiser and nearly a decade perfecting their platform, Healthily is positioned at the intersection of AI healthcare and cost reduction—a compelling proposition as insurers face mounting pressure to control spending while improving member experience.

Weird and wonderful

🍃 Sweet solution for hair loss. Scientists discovered that stevioside - the natural sweetener from Stevia plants - can actually help regrow hair! Researchers found this compound dramatically boosts how well minoxidil (the leading baldness treatment) penetrates skin and reaches hair follicles.

The breakthrough came when they created a dissolving patch combining stevioside with minoxidil, which successfully reactivated dormant hair follicles in mice with alopecia. This is huge because regular minoxidil barely penetrates skin, requiring months of daily use for minimal results.

Androgenetic alopecia (pattern baldness) affects millions worldwide, yet current treatments remain frustratingly ineffective. Now, the same plant compound making your guilt-free sodas taste sweet could revolutionize hair restoration - making treatments more natural, efficient, and accessible.

Who knew the secret to luscious locks was hiding in your sugar substitute all along? Talk about a sweet deal for your scalp!

Thank you for reading the Healthy Innovations newsletter!

Keep an eye out for next week’s issue, where I will highlight the healthcare innovations you need to know about.

Have a great week!

Alison ✨

P.S. If you enjoyed reading the Healthy Innovations newsletter, please subscribe so I know the content is valuable to you!